Indaba Capital Management, L.P. Merrimack Pharmaceuticals Inc Transaction History

Indaba Capital Management, L.P.

  • $119 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$12.02 - $13.41 $1.04 Million - $1.16 Million
86,657 Added 63.34%
223,459 $3 Million
Q3 2023

Nov 14, 2023
BUY
$11.6 - $12.52 $1.59 Million - $1.71 Million
136,802 New
136,802 $1.69 Million

Others Institutions Holding MACK

# of Institutions
2
Shares Held
349
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Indaba Capital Management, L.P. Portfolio

Follow Indaba Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Indaba Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Indaba Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email